NurExone Biologic, Inc. is a pharmaceutical company, which engages in the development and commercialization of biological extracellular vesicles-based technology drug platforms. The firm is engaged in developing a platform for biologically guided exosome-based therapies to be delivered, minimally invasive, to patients who have suffered central nervous system injuries. The Company’s first product, ExoPTEN for acute spinal cord injury, uses exosomes loaded with a specific and proprietary sIRNA sequence as the active pharmaceutical ingredient. Its ExoTherapy is a proprietary platform for developing exosome-based therapies. The NurExone platform technology is expected to offer solutions to drug companies interested in minimally invasive targeted drug delivery for other indications.
Follow-Up Questions
What is the price performance of NRXBF stock?
The current price of NRXBF is $0.7421, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Nurexone Biologic Inc?
Nurexone Biologic Inc belongs to Biotechnology industry and the sector is Health Care
What is Nurexone Biologic Inc market cap?
Nurexone Biologic Inc's current market cap is $60.4M
Is Nurexone Biologic Inc a buy, sell, or hold?
According to wall street analysts, 5 analysts have made analyst ratings for Nurexone Biologic Inc, including 3 strong buy, 5 buy, 1 hold, 0 sell, and 3 strong sell
